Our investigators and research teams are the foundation of our clinical research enterprise. The Dignity Health Research Institute is a vested participant in the processes of research and innovation designed to have a significant impact on health outcomes across the many communities DHRI serves. Our 1000+ active clinical trials and research protocols represents a significant opportunity to our physicians and health sciences professionals that wish to engage in clinical trials and pilot innovations in care delivery. We celebrate our research communities, network with peers, and collaborate on shaping Dignity Health’s research mission and vision across the enterprise.
Please see the links and resources below to learn more about how research is reviewed and approved at Dignity Health or about resources available to our investigators, research teams, clinicians, and employees interested in conducting clinical research. For any additional questions or concerns, please contact us at 916-851-2283 or by emailing us at [email protected]
Frequently Asked Questions
Dignity Health follows a standard research review and approval process for all facilities engaged in research. Dignity Health Research Institute manages this process when any research endeavor requires access to Dignity Health patients, patient data, employees, medical staff, health care services and/or use of our campuses.
Click here for a more detailed description of this process.
DHRI has dedicated personnel to ensure that all research staff have access to the proper resources and are up to date on the most recent regulations and policies. For any training related questions, requests, or concerns please reach out to the Training and Education Analyst at 916-851-2685. To access CITI please click here.
Research is defined as a systematic investigation involving human subjects, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge. “Human Subjects” are living individuals about whom investigators (whether professional or student) conducting research are:
a) Obtaining information or bio specimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or bio specimens;
b) Obtaining, using, studying, analyzing, or generating identifiable private information or identifiable bio specimens.
Click here to use the OHRP Human Subjects Decision tree as a helpful tool.
To find out if your research is considered Human Subjects Research, please contact us at 916-851-2283 or by emailing us at [email protected]
An Institutional Review Board (IRB) is a committee charged with protecting the rights and welfare of people participating in research activities. The IRB reviews and approves research applications involving human subjects, provides ongoing oversight to ensure regulatory compliance, and assures that the risks to research subjects are minimized and participation by these subjects is done so on a voluntary, informed basis. Both the Food and Drug Administration and the Office for Human Research Protections set the guidelines and regulations governing human subjects research and establish the authority granted to the IRB. The IRB highly encourages all investigators, coordinators, sponsors and research volunteers to contact the IRB for questions, advice or concerns at any time. Any questions, concerns or suggestions will be responded to in a confidential and professional manner.
Dignity Health Research Institute Policies and Procedures assure that all research conducted at a Dignity Health facility adheres to all applicable laws, regulations and ethical guidelines.
- Administration DHRI CA/NV
- Research Finance DHRI CA/NV
- IRB Operations DHRI CA/NV
- Research Operations DHRI CA/NV
- Responsible Conduct for Research DHRI CA/NV
Clinical trials are used to study many aspects of medical care, including:
•Treatment trials: These focus on testing new drugs or surgical procedures;
•Prevention trials: These test a variety of ways people can prevent disease;
•Diagnostic trials: Look for better procedures to diagnose a disease or condition;
•Screening trials: Test the best way to detect a health condition or a disease; and
•Quality of life trials: Investigate ways to improve the quality of life for people living with a chronic illness.
The government has strict guidelines and safeguards in place to protect people who volunteer to participate in a clinical trial. In the United States, each clinical trial must be approved and monitored by a local Institutional Review Board (IRB) to ensure the risks to the study participants are as low as possible. An IRB is an independent committee of physicians, statisticians, and community advocates, among others, that ensure a clinical trial is ethical and the rights of research volunteers are protected. All institutions that conduct or support biomedical research involving people must, by federal regulation, have an IRB that initially approves and periodically reviews the research.
Clinical trials may be sponsored by a government agency, a pharmaceutical company, an individual physician, a healthcare organization, a university, an organization that creates medical devices, or a physician's office. In some instances, additional research is approvedtesting or physician visits may be required. The cost of these extra tests may be covered by the study, although you or your insurance company may ultimately be responsible for the additional costs incurred. Information regarding this topic will be outlined in the research volunteer's Informed Consent.